Abstract
Cysteine proteases are important therapeutic targets for numerous disease states including arthritis, osteoporosis, African sleeping sickness and Chagas disease. They have been shown to be viable drug targets for parasitic diseases through in vitro and animal model studies. This review examines the development of vinyl sulfone containing cysteine protease inhibitors. Peptidyl vinyl sulfones are superior inhibitors as they comprise the reactive vinyl sulfone warhead in addition to the peptide backbone, which has complementarity with the enzyme active site. The design, synthesis and activity of these protease inhibitors are discussed. Additionally, different methods for the preparation of vinyl sulfones are presented.
Keywords: Cruzain, cysteine proteases, parasitic inhibiotrs, peptides, rhodesain, vinyl sulfones, therapeutics targets, drug targets, parasitic diseases, metalloproteases
Current Bioactive Compounds
Title: Vinyl Sulfone Containing Parasitic Cysteinyl Protease Inhibitors
Volume: 7 Issue: 4
Author(s): Elizabeth Dunny and Paul Evans
Affiliation:
Keywords: Cruzain, cysteine proteases, parasitic inhibiotrs, peptides, rhodesain, vinyl sulfones, therapeutics targets, drug targets, parasitic diseases, metalloproteases
Abstract: Cysteine proteases are important therapeutic targets for numerous disease states including arthritis, osteoporosis, African sleeping sickness and Chagas disease. They have been shown to be viable drug targets for parasitic diseases through in vitro and animal model studies. This review examines the development of vinyl sulfone containing cysteine protease inhibitors. Peptidyl vinyl sulfones are superior inhibitors as they comprise the reactive vinyl sulfone warhead in addition to the peptide backbone, which has complementarity with the enzyme active site. The design, synthesis and activity of these protease inhibitors are discussed. Additionally, different methods for the preparation of vinyl sulfones are presented.
Export Options
About this article
Cite this article as:
Dunny Elizabeth and Evans Paul, Vinyl Sulfone Containing Parasitic Cysteinyl Protease Inhibitors, Current Bioactive Compounds 2011; 7 (4) . https://dx.doi.org/10.2174/157340711798375859
DOI https://dx.doi.org/10.2174/157340711798375859 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
Current Hypertension Reviews Mechanisms of the Beneficial Actions of Ischemic Preconditioning on Subcellular Remodeling in Ischemic-Reperfused Heart
Current Cardiology Reviews Torasemide for the Treatment of Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Body Composition and -174G/C Interleukin-6 Promoter Gene Polymorphism: Association with Progression of Insulin Resistance in Normal Weight Obese Syndrome
Current Pharmaceutical Design Diagnosis and Therapeutic Approaches to Transthyretin Amyloidosis
Current Medicinal Chemistry Non Alcoholic Fatty Liver: Epidemiology and Natural History
Reviews on Recent Clinical Trials The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19
Current Psychopharmacology Magnetomotive Molecular Nanoprobes
Current Medicinal Chemistry Effect of Non-Vegetarian Diet on Cardiovascular Reactivity to Mental Stress in Young Adults
Vascular Disease Prevention (Discontinued) Meet Our Editorial Board Member
Current Medical Imaging Pharmacogenomic Considerations of the Insertion / Deletion Gene Polymorphism of the Angiotensin I-Converting Enzyme and Coronary Artery Disease
Current Vascular Pharmacology Cathinone Neurotoxicity (“The “3Ms”)
Current Neuropharmacology Vitamin D status in coronary artery disease: association with IL-35 and TGF-β1 and disease severity
Endocrine, Metabolic & Immune Disorders - Drug Targets The Circulating Endothelial Cell in Cancer: Towards Marker and Target Identification
Current Pharmaceutical Design Resveratrol and Cancer Treatment: Is Hormesis a Yet Unsolved Matter?
Current Pharmaceutical Design Controlled Release of Growth Factors for Regenerative Medicine
Current Pharmaceutical Design Drug Eluting Stents: Friend or Foe? A Review of Cellular Mechanisms Behind the Effects of Paclitaxel and Sirolimus Eluting Stents
Current Drug Metabolism Novel Therapeutic Targets for Phosphodiesterase 5 Inhibitors: current state-of-the-art on systemic arterial hypertension and atherosclerosis
Current Pharmaceutical Biotechnology G-Protein Coupled Receptors (GPCRs): A Comprehensive Computational Perspective
Combinatorial Chemistry & High Throughput Screening Cognitive Decline as a Consequence of Essential Hypertension
Current Pharmaceutical Design